v3 Template
O

Organogenesis Holdings Inc.

Biomedicine / Regenerative Medicine ~105 employees
Founded
--
Employees (Est.)
~105
7 leaders known
Total Funding
$130.0M
Funding Rounds
1
Last Funding
2024-11-12

About Organogenesis Holdings Inc.

Organogenesis is a company focused on regenerative tissue innovations, aiming to elevate the standard of care by delivering transformative solutions in biomedicine. Their mission is to empower healing through advanced wound care, surgical, and sports medicine solutions, driven by science and a commitment to innovation.

Products & Services

Advanced Wound Care:A range of products including PuraPlyAM, PuraPly, NuShield, Affinity, Apligraf, Novachor, CYGNUS Dual, CYGNUS Matrix, VIA Matrix, and SimpliGraft, designed to support wound healing and tissue regeneration.
Surgical & Sports Medicine:Products such as NuShield, Affinity, FiberOS, OCMP, PuraPly SX, PuraPly MZ, and PuraForce, focused on surgical applications and sports medicine to aid in tissue repair and regeneration.
Physician Solutions:Support services and solutions tailored for physicians to enhance patient care in wound and surgical contexts.
Patient & Provider Support:Programs like the Circle of Care, offering reimbursement support, customer care, and medical-technical assistance for patients and healthcare professionals.

Specialties

Regenerative Tissue Innovations Advanced Wound Care Surgical Solutions Sports Medicine

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A Convertible Preferred Stock Private Placement
T: -
FT: Series A Convertible Preferred Stock Private Placement
A: 130000000
MR: -
FA: $130 million
FAN: 130000000
D: 2024-11-12
FD: 2024-11-12
1 investors
Series A Convertible Preferred Stock Private Placement Latest
2024-11-12
$130.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

G

Gary S. Gillheeney, Sr.

President, Chief Executive Officer and Chair of the Board

D

David C. Francisco

Chief Financial Officer

P

Patrick Bilbo

Chief Operating Officer

B

Brian Grow

Chief Commercial Officer

L

Lori Freedman

Chief Administrative and Legal Officer

A

Antonio S. Montecalvo

Vice President, Health Policy

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Organogenesis Holdings Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biomedicine / Regenerative Medicine
Company Size
~105 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro